← All Kiromic Biopharma, INC filings

Kiromic Biopharma, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma CEO Pietro Bersani Increases Stake in Company
Kiromic Biopharma's CEO, Pietro Bersani, recently purchased additional shares of the company's common stock, increasing his holdings.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma CFO Increases Stake in Company
Brian Hungerford, CFO of Kiromic Biopharma, recently acquired additional shares of the company's common stock through open market purchases.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma CFO Brian Hungerford Acquires 2,000 Shares
Brian Hungerford, CFO of Kiromic Biopharma, recently purchased 2,000 shares of the company's common stock at a price of $1.75 per share.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma Director Pamela Misajon Increases Stake in Company
Director Pamela Misajon recently purchased additional shares of Kiromic Biopharma, Inc., signaling a potential vote of confidence in the company.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma CFO Brian Hungerford Acquires 1,000 Shares
Kiromic Biopharma's CFO, Brian Hungerford, purchased 1,000 shares of common stock at $2.60 per share on June 13, 2024.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma Director Michael Nagel Acquires 1,000 Shares
Director Michael Nagel of Kiromic Biopharma, Inc. purchased 1,000 shares of common stock on June 11, 2024.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma Director Pamela Misajon Reports Transaction
Pamela Misajon, a director at Kiromic Biopharma, reported a transaction involving the company's common stock on June 10, 2024.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma CFO Brian Hungerford Acquires 1,000 Shares
Brian Hungerford, CFO of Kiromic Biopharma, recently purchased 1,000 shares of the company's common stock at a price of $3.18 per share.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma CEO Pietro Bersani Increases Stake in Company
Kiromic Biopharma CEO Pietro Bersani recently purchased additional shares of the company's common stock.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma Director Ralston Reports Acquisition of $2 Million Convertible Note
Director Shannon Ralston reports acquiring a $2 million Senior Secured Convertible Note in Kiromic Biopharma on June 3, 2024.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma CFO Receives and Modifies Restricted Stock Awards
Brian Hungerford, CFO of Kiromic Biopharma, received restricted stock awards and modified existing restricted stock units.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma CEO Pietro Bersani Receives Restricted Stock Award
Kiromic Biopharma's CEO, Pietro Bersani, was granted a restricted stock award of 45,968 shares on May 3, 2024, vesting on April 1, 2025.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma Director Michael Catlin Receives Restricted Stock Award
Director Michael Catlin of Kiromic Biopharma, Inc. reports the acquisition of 18,000 shares of restricted stock.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma Director Pamela Misajon Receives Restricted Stock Award
Director Pamela Misajon of Kiromic Biopharma, Inc. was granted 18,000 shares of restricted stock on March 18, 2024.
KRBP
Kiromic Biopharma, INC
Form 4: Kiromic Biopharma Director Michael Nagel Receives Restricted Stock Award
Director Michael Nagel of Kiromic Biopharma, Inc. reports the acquisition of 18,000 shares of restricted stock.